Acute kidney injury (AKI) is a major public health problem with high incidence and mortality.
As a form of programmed cell death (PCD), ferroptosis could be considered as a process of …

Continuous renal replacement therapy (CRRT) is commonly used to provide renal support
for critically ill patients with acute kidney injury, particularly patients who are …

Results There were 312 studies identified (n= 49,147,878), primarily in hospital settings.
Most studies originated from North America, Northern Europe, and Eastern Asia, from high …

Acute kidney injury (AKI) is a widespread problem of epidemic status. Compelling evidence
indicates that the incidence of AKI is rapidly increasing, particularly among hospitalized …

Early detection of kidney disease is of vital importance due to its current prevalence
worldwide. Fluorescence imaging, especially in the second near‐infrared window (NIR‐II) …

Executive summary Acute kidney injury (AKI) is a major contributor to poor patient outcomes.
AKI occurs in about 13· 3 million people per year, 85% of whom live in the developing world …

AKI is pathologically characterized by sublethal and lethal damage of renal tubules. Under
these conditions, renal tubular cell death may occur by regulated necrosis (RN) or …

Acute kidney injury (AKI) is a common clinical state resulting from pathogenic conditions
such as ischemic and toxic insults. The pathophysiology of AKI shares common pathogenic …

There is increasing recognition that acute kidney injury (AKI) and chronic kidney disease
(CKD) are closely linked and likely promote one another. Underlying CKD now is …

Rationale: We recently reported two novel biomarkers for acute kidney injury (AKI), tissue
inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein 7 …